Genworth Financial Inc (GNW) concluded trading on Wednesday at a closing price of $7.53, with 7.54 million shares of worth about $56.75 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.96% during that period and on July 09, 2025 the price saw a loss of about -3.59%. Currently the company’s common shares owned by public are about 415.88M shares, out of which, 405.29M shares are available for trading.
Stock saw a price change of -4.32% in past 5 days and over the past one month there was a price change of 8.19%. Year-to-date (YTD), GNW shares are showing a performance of 25.71% which increased to 7.73% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.95 but also hit the highest price of $8.08 during that period. The average intraday trading volume for Genworth Financial Inc shares is 7.67 million. The stock is currently trading -0.36% below its 20-day simple moving average (SMA20), while that difference is up 4.52% for SMA50 and it goes to 6.71% higher than SMA200.
Genworth Financial Inc (NYSE: GNW) currently have 415.88M outstanding shares and institutions hold larger chunk of about 87.41% of that.
The stock has a current market capitalization of $3.12B and its 3Y-monthly beta is at 1.12. PE ratio of stock for trailing 12 months is 15.28, while it has posted earnings per share of $0.49 in the same period. Its PEG reads 14.42 while making debt-to-equity ratio of 0.17. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GNW, volatility over the week remained 2.72% while standing at 3.05% over the month.
Stock’s fiscal year EPS is expected to drop by -29.03% while it is estimated to increase by 18.18% in next year. EPS is likely to grow at an annualized rate of 1.06% for next 5-years, compared to annual growth of -5.65% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Keefe Bruyette on June 18, 2025 offering an Outperform rating for the stock and assigned a target price of $9 to it. On May 05, 2016, Compass Point Reiterated their recommendations, while on February 08, 2016, Compass Point Reiterated their ratings for the stock with a price target of $5.50. Stock get a Neutral rating from Goldman on November 17, 2015.
